HIGHLIGHTS
- who: Xiaoxia Cheng and colleagues from the School of Basic Medical Science, Henan University, Kaifeng, China have published the Article: Application Prospects of Triphenylphosphine-Based Mitochondria-Targeted Cancer Therapy, in the Journal: Cancers 2023, 666 of 21/01/2023
- what: The authors review the various pro-mitochondrial agents that have been developed, particularly the lipophilic cationic triphenylphosphine and discuss the advantages of TPP in mitochondrial targeting functions and the challenges associated with the application of TPP-based mitochondria-targeted anticancer drugs for oncology therapy and mitochondria-targeted drug delivery systems based on lipophilic cations. While . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.